How reframing drug use as a public health issue reshaped state capacity without normalizing consumption
At the turn of the century, Portugal faced a paradox that many governments still struggle to resolve. Drug use was widespread, overdose deaths and HIV infections were climbing, yet decades of criminal enforcement had failed to contain the problem. Courts and prisons were saturated with low-level drug cases, while the underlying social and health indicators continued to deteriorate. The tension was no longer about drugs themselves, but about whether the state’s chosen tools were capable of producing the outcomes it claimed to seek.
Portugal’s response was not a moral conversion, nor a declaration of permissiveness. It was a calculated institutional decision: to stop treating drug consumption as a criminal offense and instead manage it through administrative and public health mechanisms. Decriminalization, in this sense, was less about tolerance and more about reallocating state capacity toward measurable harm reduction.
The core dilemma policymakers confronted was straightforward but politically risky. Persisting with criminalization signaled toughness but delivered poor results; abandoning it risked accusations of surrender. Portugal resolved this tension by changing the policy objective without abandoning prohibition altogether. Drugs remained illegal to produce and distribute, but possession for personal use was removed from the criminal justice system and redirected toward assessment, treatment, and social support.
This choice mattered institutionally. By removing user-level cases from courts, the state reduced enforcement congestion and redirected resources toward trafficking and organized crime. More importantly, it aligned responsibility for the problem with institutions better suited to manage it. Health authorities, rather than police and judges, became central actors. The result was not an absence of control, but a different kind of control—administrative rather than punitive.
The outcomes that followed illustrate why this shift endured. Severe public health harms declined, particularly those linked to injection drug use. Overdose deaths fell relative to comparable countries, and treatment uptake increased. Crucially, these improvements did not coincide with a surge in overall drug consumption. Use patterns largely tracked regional trends, undermining the assumption that criminal penalties are the primary deterrent.
What makes the Portuguese case analytically significant is not that decriminalization “worked” in an abstract sense, but why it worked. The policy succeeded because it was embedded in a broader institutional design that prioritized coordination, continuity, and capacity. Decriminalization alone was not the solution; it was the enabling condition for a health-centered system to function effectively.
The case also highlights an often-overlooked constraint: international law. Portugal did not legalize drugs, nor did it attempt to dismantle the prohibition framework. By operating within existing international conventions, policymakers preserved legal credibility while exploiting the flexibility those frameworks allow at the domestic level. This balance insulated the reform from external pressure and reduced its political vulnerability.
Over time, the policy became self-reinforcing. As outcomes improved, the institutional arrangement gained legitimacy across political cycles. What began as a contested reform evolved into a stable policy equilibrium, not because it resolved all aspects of drug use, but because it delivered results that alternative approaches had failed to achieve.
Portugal’s experience suggests a broader analytical lesson. Drug policy is not primarily a debate about permissiveness versus control; it is a question of institutional fit. When policy tools are mismatched to the problem they are meant to solve, states incur high costs for low returns. By redefining drug use as a governance problem of health and capacity rather than morality and punishment, Portugal demonstrated how reframing objectives can quietly transform outcomes—without ever pretending the problem itself had disappeared.
This article is based on the PoliticLab case study “Drug Decriminalization in Portugal” (Public Policy & Policy Outcomes), which examines the policy’s institutional design, constraints, and outcomes through a political analysis framework.